Not Yet Recruiting OBSERVATIONAL NCT06385067

Treatment of Primary Coronary Artery Vascular Lesions With Biolimus Coated Coronary Balloon Dilation Catheter

Prospective, International Multicenter Clinical Study Evaluating the Safety and Efficacy of the Biolimus Coated Coronary Artery Balloon Dilation Catheter (BioAscend) in the Treatment of Primary Coronary Artery Disease in the Real World

Sponsor: JW Medical Systems Ltd

Conditions Coronary Artery Disease

Interventions Biolimus Coated Coronary Artery Balloon Dilation Catheter

Updated 3 times since 2024 Last updated: Apr 23, 2024 Started: May 10, 2024 Primary completion: Dec 30, 2025 Completion: Dec 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06385067, this observational or N/A phase trial focuses on Coronary Artery Disease and remains actively recruiting participants. Sponsored by JW Medical Systems Ltd, it has been updated 3 times since 2024, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
May 2024 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

JW Medical Systems Ltd

Data source: JW Medical Systems Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.